The best indicator for Incyte (INCY)
We backtested 366 indicators across daily, weekly and hourly charts on real Incyte (INCY) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Relative Volume Spike
On the daily chart, this is the strongest risk-adjusted edge we found for Incyte (INCY) over ~32.5 years — beating buy-and-hold by 3.5% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for Incyte (INCY) — trailing buy-and-hold by 2.2% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Relative Volume Spike ✓ | Daily | 16.6% | 0.66 | -63.2% | 50.8% | 191 | 3.5% |
| 2 | Coppock Curve ✓ | Daily | 19.8% | 0.63 | -75.2% | 40.7% | 194 | 6.7% |
| 3 | Linear Regression Slope ✓ | Daily | 18.5% | 0.61 | -82.3% | 40.2% | 199 | 5.4% |
| 4 | Squeeze Momentum ✓ | Daily | 16.0% | 0.61 | -51.9% | 44.5% | 416 | 3.0% |
| 5 | Correlation Trend ✓ | Daily | 18.5% | 0.61 | -82.3% | 40.2% | 199 | 5.4% |
| 6 | Supertrend (7,2) ✓ | Daily | 18.6% | 0.61 | -73.4% | 41.4% | 191 | 5.5% |
| 7 | TEMA 20/50 Cross | Daily | 18.3% | 0.6 | -75.0% | 43.3% | 171 | 5.2% |
| 8 | SMA 10/40 Cross | Daily | 17.4% | 0.58 | -82.8% | 43.2% | 125 | 4.3% |
| 9 | Hull MA 20/80 Cross ✓ | Daily | 17.7% | 0.58 | -80.1% | 44.8% | 183 | 4.6% |
| 10 | Hull MA 100 Trend | Daily | 16.1% | 0.57 | -71.2% | 40.7% | 231 | 3.0% |
| 11 | Zero-Lag LSMA | Weekly | 17.3% | 0.57 | -80.0% | 48.6% | 109 | 4.4% |
| 12 | SMA 10/30 Cross | Daily | 16.3% | 0.56 | -83.0% | 37.0% | 154 | 3.2% |
| 13 | Supertrend Fast (10,2) ✓ | Daily | 16.2% | 0.56 | -76.0% | 40.0% | 195 | 3.1% |
| 14 | ZLEMA 100 Trend | Daily | 15.5% | 0.56 | -68.7% | 36.9% | 282 | 2.5% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Incyte (INCY), Relative Volume Spike on the daily timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.